UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 333

Sortiert nach

Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension

The European respiratory journal, 2019-01, Vol.53 (1), p.1801906

2019

Volltextzugriff (PDF)

Five-Year Outcomes of Patients Enrolled in the REVEAL Registry

Chest, 2015-10, Vol.148 (4), p.1043-1054

2015

Volltextzugriff (PDF)

Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension

Chest, 2021-01, Vol.159 (1), p.337-346

2021

Volltextzugriff (PDF)

The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension

Chest, 2012-02, Vol.141 (2), p.354-362

2012

Volltextzugriff (PDF)

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

The European respiratory journal, 2019-06, Vol.53 (6), p.1802004

2019

Volltextzugriff (PDF)

World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation

The Journal of heart and lung transplantation, 2012-09, Vol.31 (9), p.913-933

2012

Volltextzugriff (PDF)

Pulmonary Arterial Hypertension: Epidemiology and Registries

Journal of the American College of Cardiology, 2013-12, Vol.62 (25), p.D51-D59

2013

Volltextzugriff (PDF)

Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance

The Journal of heart and lung transplantation, 2015-03, Vol.34 (3), p.362-368

2015

Volltextzugriff (PDF)

Risk Assessment Tools in Pulmonary Arterial Hypertension. Prognosis for Prospective Trials?

American journal of respiratory and critical care medicine, 2018-04, Vol.197 (7), p.843-845

2018

Volltextzugriff (PDF)

Ethical considerations of thoracic transplant and circulatory support during the COVID-19 pandemic: A closer look at pulmonary vascular disease

The Journal of heart and lung transplantation, 2020-08, Vol.39 (8), p.852-853

2020

Volltextzugriff (PDF)

Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review

The Journal of heart and lung transplantation, 2021-03, Vol.40 (3), p.172-182

2021

Volltextzugriff (PDF)

Interventional and Surgical Modalities of Treatment in Pulmonary Hypertension

Journal of the American College of Cardiology, 2009-06, Vol.54 (1), p.S67-S77

2009

Volltextzugriff (PDF)

Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial

Chest, 2023-12, Vol.164 (6), p.1518-1530

2023

Volltextzugriff (PDF)

Safety and efficacy of RT234 vardenafil inhalation powder on exercise parameters in pulmonary arterial hypertension: phase II, dose-escalation study design

Respiratory research, 2022-12, Vol.23 (1), p.355-355, Article 355

2022

Volltextzugriff (PDF)

Risk stratification in pulmonary arterial hypertension using Bayesian analysis

The European respiratory journal, 2020-08, Vol.56 (2), p.2000008

2020

Volltextzugriff (PDF)

Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: A Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis

The Journal of heart and lung transplantation, 2015-03, Vol.34 (3), p.356-361

2015

Volltextzugriff (PDF)

Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2015-12, Vol.192 (11), p.1345-1354

2015

Volltextzugriff (PDF)

Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension

The Journal of heart and lung transplantation, 2018-03, Vol.37 (3), p.365-375

2018

Volltextzugriff (PDF)

Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study

The Journal of heart and lung transplantation, 2022-03, Vol.41 (3), p.411-420

2022

Volltextzugriff (PDF)

Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry: Enrollment Characteristics and 1-Year Follow-up

Chest, 2021-11, Vol.160 (5), p.1822-1831

2021

Volltextzugriff (PDF)

Risk scores as a surrogate in pulmonary arterial hypertension: a different lens

The lancet respiratory medicine, 2024-03, Vol.12 (3), p.e9-e10

2024

Volltextzugriff (PDF)

Phenotypes of idiopathic pulmonary arterial hypertension

The lancet respiratory medicine, 2022-10, Vol.10 (10), p.e89-e89

2022

Volltextzugriff (PDF)

Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation

JACC. Heart failure, 2017-02, Vol.5 (2), p.81-88

2017

Volltextzugriff (PDF)

The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase

European respiratory review, 2024-01, Vol.33 (171), p.230183

2024

Volltextzugriff (PDF)

Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension

American journal of respiratory and critical care medicine, 2015-01, Vol.191 (2), p.208-218

2015

Volltextzugriff (PDF)

1 – 25 von 333

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(317)
Mit Volltextzugriff
(312)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension

Five-Year Outcomes of Patients Enrolled in the REVEAL Registry

Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension

The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation

Pulmonary Arterial Hypertension: Epidemiology and Registries

Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance

Risk Assessment Tools in Pulmonary Arterial Hypertension. Prognosis for Prospective Trials?

Ethical considerations of thoracic transplant and circulatory support during the COVID-19 pandemic: A closer look at pulmonary vascular disease

Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review

Interventional and Surgical Modalities of Treatment in Pulmonary Hypertension

Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial

Safety and efficacy of RT234 vardenafil inhalation powder on exercise parameters in pulmonary arterial hypertension: phase II, dose-escalation study design

Risk stratification in pulmonary arterial hypertension using Bayesian analysis

Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: A Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis

Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension

Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension

Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study

Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry: Enrollment Characteristics and 1-Year Follow-up

Risk scores as a surrogate in pulmonary arterial hypertension: a different lens

Phenotypes of idiopathic pulmonary arterial hypertension

Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation

The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase

Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension

Aktive Filter

Suchergebnisse filtern